L Shen, J Guo, Q Zhang, H Pan, Y Yuan… - … for immunotherapy of …, 2020 - ncbi.nlm.nih.gov
Background Tislelizumab is an investigational, humanized, IgG4 monoclonal antibody with
high affinity and binding specificity for programmed cell death-1 (PD-1) that was engineered …